Reuters logo
BRIEF-U.S. FDA says issued a warning letter to Abbott Laboratories
April 13, 2017 / 2:22 PM / 5 months ago

BRIEF-U.S. FDA says issued a warning letter to Abbott Laboratories

April 13 (Reuters) - U.S. Food and Drug Administration :

* Says issued a warning letter to Abbott Laboratories

* Says raises quality concerns after inspection of St. Jude’s Sylmar facility

* Says to Abbott failure to correct violations may result in regulatory action without further notice Source text - bit.ly/2pw2NlM Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below